Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

CUSIP: 19249H103

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
153,624,096
Total 13F shares
29,921,898
Share change
+1,791,948
Total reported value
$842,300,808
Put/Call ratio
253%
Price per share
$28.15
Number of holders
122
Value change
+$50,764,547
Number of buys
68
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.2%
6,507,031
$174,259,000 30 Sep 2016
13F
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
2%
3,055,055
$81,814,000 30 Sep 2016
13F
JPMORGAN CHASE & CO
13F
Company
1.3%
1,930,979
$51,712,000 30 Sep 2016
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1%
1,550,233
$41,515,000 30 Sep 2016
13F
BlackRock Fund Advisors
13F
Company
0.9%
1,389,802
$37,219,000 30 Sep 2016
13F
VANGUARD GROUP INC
13F
Company
0.67%
1,029,701
$27,575,000 30 Sep 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.66%
1,006,817
$26,963,000 30 Sep 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.54%
831,322
$22,263,000 30 Sep 2016
13F
STATE STREET CORP
13F
Company
0.52%
801,707
$21,466,000 30 Sep 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.47%
715,475
$19,160,000 30 Sep 2016
13F
ORBIMED ADVISORS LLC
13F
Company
0.44%
671,600
$17,985,000 30 Sep 2016
13F
Cormorant Asset Management, LP
13F
Company
0.38%
576,106
$15,428,000 30 Sep 2016
13F
Rock Springs Capital Management LP
13F
Company
0.3%
467,500
$12,520,000 30 Sep 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.3%
463,914
$12,424,000 30 Sep 2016
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.25%
380,092
$10,179,000 30 Sep 2016
13F
NORTHERN TRUST CORP
13F
Company
0.25%
378,017
$10,123,000 30 Sep 2016
13F
HIGHLAND CAPITAL MANAGEMENT LP
13F
Company
0.24%
372,505
$9,976,000 30 Sep 2016
13F
LORD, ABBETT & CO. LLC
13F
Company
0.24%
363,734
$9,740,000 30 Sep 2016
13F
BRIDGER MANAGEMENT, LLC
13F
Company
0.23%
359,886
$9,638,000 30 Sep 2016
13F
BROWN ADVISORY INC
13F
Company
0.21%
322,902
$8,648,000 30 Sep 2016
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.21%
316,177
$8,467,000 30 Sep 2016
13F
VHCP Management, LLC
13F
Company
0.2%
305,505
$8,181,000 30 Sep 2016
13F
AXA S.A.
13F
Company
0.2%
303,822
$8,136,000 30 Sep 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
216,161
$5,787,000 30 Sep 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.13%
206,988
$5,540,000 30 Sep 2016
13F
Bellevue Group AG
13F
Company
0.13%
202,000
$5,410,000 30 Sep 2016
13F
S.c.a. Candriam
13F
Individual
0.12%
191,000
$5,115,000 30 Sep 2016
13F
CREDIT SUISSE AG/
13F
Company
0.11%
172,239
$4,612,000 30 Sep 2016
13F
C WorldWide Group Holding A/S
13F
Company
0.1%
156,800
$4,199,000 30 Sep 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.09%
145,379
$3,893,000 30 Sep 2016
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.09%
145,000
$3,883,000 30 Sep 2016
13F
Allianz Asset Management GmbH
13F
Company
0.09%
142,305
$3,741,000 30 Sep 2016
13F
Bank of New York Mellon Corp
13F
Company
0.09%
134,126
$3,592,000 30 Sep 2016
13F
Rhenman & Partners Asset Management AB
13F
Company
0.09%
131,357
$3,517,740 30 Sep 2016
13F
VHCP Management II, LLC
13F
Company
0.08%
129,629
$3,471,000 30 Sep 2016
13F
CITADEL ADVISORS LLC
13F
Company
0.08%
119,231
$3,192,000 30 Sep 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.08%
116,060
$3,108,000 30 Sep 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.07%
113,833
$3,049,000 30 Sep 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.07%
101,673
$2,723,000 30 Sep 2016
13F
Lombard Odier Asset Management (Switzerland) SA
13F
Company
0.07%
100,000
$2,678,000 30 Sep 2016
13F
Spark Investment Management LLC
13F
Company
0.06%
84,900
$2,273,000 30 Sep 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.05%
77,869
$2,085,000 30 Sep 2016
13F
Sio Capital Management, LLC
13F
Company
0.05%
73,053
$1,956,000 30 Sep 2016
13F
HBK INVESTMENTS L P
13F
Company
0.04%
63,500
$1,701,000 30 Sep 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
62,440
$1,672,000 30 Sep 2016
13F
MACQUARIE GROUP LTD
13F
Company
0.04%
58,255
$1,560,000 30 Sep 2016
13F
MORGAN STANLEY
13F
Company
0.04%
56,873
$1,523,000 30 Sep 2016
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.04%
54,829
$1,468,000 30 Sep 2016
13F
Numeric Investors LLC
13F
Company
0.04%
54,700
$1,465,000 30 Sep 2016
13F
Emerald Acquisition Ltd.
13F
Company
0.03%
52,111
$1,395,000 30 Sep 2016
13F

Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2016

As of 31 Dec 2016, Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,921,898 shares. The largest 10 holders included FMR LLC, Kohlberg Kravis Roberts & Co. L.P., JPMORGAN CHASE & CO, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BlackRock Institutional Trust Company, N.A.. This page lists 122 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
116
Q4 2016 holders
122
Holder diff
6
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 Value $ Q4 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .